Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

Abstract Introduction Carbapenems (CR) have traditionally been the first line treatment for bacteremia caused by AmpC-producing Enterobacterales. However, CR have a high ecological impact, and carbapenem-resistant strains continue rising. Thus, other treatment alternatives like Piperacillin-Tazobact...

Full description

Bibliographic Details
Main Authors: M. Ávila-Núñez, O. Lima, A. Sousa, M. Represa, P. Rubiñán, P. Celestino, M. Garrido-Ventín, L. García-Formoso, F. Vasallo-Vidal, L. Martinez-Lamas, A. Pérez-Landeiro, M Rubianes, MT. Pérez-Rodríguez
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Annals of Clinical Microbiology and Antimicrobials
Subjects:
Bacteremia
Enterobacterales
AmpC-producing
Carbapenem
Cefepime
Piperacillin-tazobactam
Online Access:https://doi.org/10.1186/s12941-023-00624-9

Internet

https://doi.org/10.1186/s12941-023-00624-9

Similar Items